SFJ Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SFJ Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10879
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SFJ Pharmaceuticals Inc (SFJ Pharmaceuticals) is a pharmaceutical company that offers drug development services. The company provides management of phase III oncology clinical trials, phase III trials and regulatory approvals. It offers phase III trials for kidney cancer, lung cancer and autoimmune disease. SFJ Pharmaceuticals provides regulatory approvals for thyroid cancer, acute lymphoblastic leukemia and acute myeloid leukemia, among others. The company operates through its offices located in the US, Japan, Singapore, Korea, China, Spain and Germany. SFJ Pharmaceuticals is headquartered in Pleasanton, California, the US.

SFJ Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SFJ Pharmaceuticals Secures USD30 Million in Venture Funding 10
SFJ Pharmaceuticals Secures USD13 Million in Venture Funding 11
SFJ Pharmaceuticals Secures USD0.5 Million in Venture Funding 12
SFJ Pharmaceuticals Secures USD21 Million in Venture Funding 13
SFJ Pharmaceuticals Secures USD35 Million in Venture Funding 14
Partnerships 15
Merck Enters into Development Agreement with SFJ Pharma 15
SFJ Pharma Enters Into Co-Development Agreement With Pfizer For Dacomitinib 16
SFJ Pharmaceuticals Inc – Key Competitors 17
SFJ Pharmaceuticals Inc – Key Employees 18
SFJ Pharmaceuticals Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SFJ Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SFJ Pharmaceuticals Secures USD30 Million in Venture Funding 10
SFJ Pharmaceuticals Secures USD13 Million in Venture Funding 11
SFJ Pharmaceuticals Secures USD0.5 Million in Venture Funding 12
SFJ Pharmaceuticals Secures USD21 Million in Venture Funding 13
SFJ Pharmaceuticals Secures USD35 Million in Venture Funding 14
Merck Enters into Development Agreement with SFJ Pharma 15
SFJ Pharma Enters Into Co-Development Agreement With Pfizer For Dacomitinib 16
SFJ Pharmaceuticals Inc, Key Competitors 17
SFJ Pharmaceuticals Inc, Key Employees 18
SFJ Pharmaceuticals Inc, Other Locations 19
SFJ Pharmaceuticals Inc, Subsidiaries 19

List of Figures
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SFJ Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SFJ Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CBR Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc, is a stem cell company that offers new born stem cells. The company provides collection, processing, and long-term cryopreservation services for newborn umbilical cord blood stem cells and cord tissue units. It offers cord bloo …
  • Rising Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rising Pharmaceuticals Inc (Rising Pharma), a subsidiary of Aceto Corp, is a manufacturer and distributor of generic prescription pharmaceutical products. The company’s products include amiloride hydrochloride, benztropine, anastrozole, carisoprodol, codeine phosphate, cetirizine hydrochlori …
  • Hellix Ventures Inc. (HEL):企業概要、財務及び戦略的SWOT分析
    Summary Hellix Ventures Inc. (Hellix Ventures) is a natural resource company. The company identifies, acquires, explores, and develops resource properties in North America. Its properties include Athabasca Claims, Margarita Claims, and Star Valley. Hellix Ventures explores gold, silver, lead, zinc, …
  • Bristol-Myers Squibb Co (BMY):医療機器:M&Aディール及び事業提携情報
    Summary Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virolo …
  • G-III Apparel Group, Ltd. (GIII):企業財務及び戦略的SWOT分析
    Summary G-III Apparel Group, Ltd. (G-III) is a consumer product company that offers apparels. The company manufactures and distributes outerwear, dresses, sportswear, beachwear and women suits among others. It offers products through divisions such as outerwear, ready to wear, dresses, team sports, …
  • Ilmarinen Mutual Pension Insurance Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ilmarinen Mutual Pension Insura …
  • Royal Unibrew A/S:企業概要・SWOT・財務分析
    Summary Canadean's "Royal Unibrew A/S : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descri …
  • Snowball Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Snowball Group Limited Mergers …
  • AG Real Estate S.A. (formerly Fortis Real Estate):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AG Real Estate S.A. (formerly F …
  • Arakawa Chemical Industries, Ltd. (4968):企業財務及び戦略的SWOT分析
    Summary Arakawa Chemical Industries, Ltd. (Arakawa Chemical) is a chemical company that manufactures and markets various chemical products, resins and intermediate materials. The company offers resin materials for producing printing inks, adhesives and PSA. It manufactures and supplies chemical addi …
  • TKC Corporation (9746):企業財務及び戦略的SWOT分析
    Summary TKC Corporation (TKC), formerly TKC K.K. is a technology service provider that offers information services. The company provides computer services such as mass output with batch service, data storage and downloading service, internet services, intranet services, application service provider …
  • Novo Nordisk AS (NOVO B):医療機器:M&Aディール及び事業提携情報
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • London Stock Exchange Group Plc:戦略・SWOT・企業財務分析
    London Stock Exchange Group Plc - Strategy, SWOT and Corporate Finance Report Summary London Stock Exchange Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • JMS Co., Ltd. (7702):企業財務及び戦略的SWOT分析
    Summary JMS Co., Ltd. (JMS) a subsidiary of JCB Co., Ltd. is a medical equipment company that offers therapeutic products. The company manufactures, markets, exports and imports medical devices and pharmaceutical products. Its products include infusion and transfusion therapy, general medical suppli …
  • Impact Developer & Contractor SA:企業の戦略・SWOT・財務情報
    Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report Summary Impact Developer & Contractor SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Union Bank of India:企業の戦略・SWOT・財務情報
    Union Bank of India - Strategy, SWOT and Corporate Finance Report Summary Union Bank of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eloxx Pharmaceuticals Inc (ELOX):企業の財務・戦略的SWOT分析
    Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BioScrip, Inc (BIOS):企業概要、財務及び戦略的SWOT分析
    Summary BioScrip, Inc (BioScrip) is an infusion care company. The company provides a range of infusion services, PBM services and respiratory services. Its infusion therapy services include antimicrobial drugs, factor replacement therapy for hemophilia, hepatitis therapy, biologic agents, also calle …
  • Rafako S.A. (RFK):企業財務及び戦略的SWOT分析
    Summary Rafako S.A. (Rafako) a subsidiary of PBG S.A. is a power generation industry that offers design and distributes boilers and environment protection plants. The company offers flue gas cleaning systems such as FGD plants and electrostatic precipitators. Its products include complete power gene …
  • American Electric Technologies, Inc. (AETI):企業のM&A・提携動向(発電分野)
    Summary American Electric Technologies, Inc. (AETI) is a power delivery solution company that provides solution to the traditional and renewable energy sectors. The company provides products that include power distribution and power conversion products. Its power distribution products comprise low v …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆